Andrew Dell

Eurofins BioPharma Product Testing (US)

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies. Our comprehensive service offerings include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products. We offer a broad range of methodologies under GMP authorization, ISO 17025 accreditation and ISO 9000 certification and all analysis are performed according to European and British Pharmacopeia (EP and BP), United States Pharmacopeia (USP) and Japanese Pharmacopeia (JP), as well as specific customer methods. With a global capacity of more than 2 million square feet and facilities spanning 19 countries, our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across 37 locations worldwide. Our local presence with four key sites in the US, including Lancaster, PA; Portage, MI; Columbia, MO; and San Diego, CA, ensures personal service backed by a unique global breadth of harmonized capabilities that supports all functional areas of bio/pharmaceutical drug development. We give clients the flexibility to choose from three service models to meet specific project needs, including the award-winning PSS Insourcing Solutions® and we also provide secure 24-hour data access via our online data portal, LabAccess.com. Eurofins BioPharma Product Testing is a brand used by several distinct legal entities. Companies using this brand in the US are (i) Eurofins Lancaster Laboratories, Inc. (ii) Eurofins Advantar Laboratories, Inc. (iii) Eurofins Biopharma Product Testing Columbia, Inc. Each of these companies is operating its business independently and separate from any of its affiliates.